尼芬那宗结构式
|
常用名 | 尼芬那宗 | 英文名 | Nifenazone |
---|---|---|---|---|
CAS号 | 2139-47-1 | 分子量 | 308.33500 | |
密度 | 1.33g/cm3 | 沸点 | N/A | |
分子式 | C17H16N4O2 | 熔点 | 252-253° (also reported as mp 256-258°) | |
MSDS | 中文版 美版 | 闪点 | N/A |
尼芬那宗用途Nifenazone 是一种吡唑类药物,可用于治疗各种风湿性疾病。 |
中文名 | 尼芬那宗 |
---|---|
英文名 | N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)pyridine-3-carboxamide |
中文别名 | 烟酰氨基比林 |
英文别名 | 更多 |
描述 | Nifenazone 是一种吡唑类药物,可用于治疗各种风湿性疾病。 |
---|---|
相关类别 | |
参考文献 |
[1]. HART FD, et al. TRIAL OF NIFENAZONE ("THYLIN"). Br Med J. 1964 Jun 13;1(5397):1553-4. |
密度 | 1.33g/cm3 |
---|---|
熔点 | 252-253° (also reported as mp 256-258°) |
分子式 | C17H16N4O2 |
分子量 | 308.33500 |
精确质量 | 308.12700 |
PSA | 68.92000 |
LogP | 2.20470 |
折射率 | 1.671 |
储存条件 | 2-8°C |
个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 2 |
RTECS号 | QS4005000 |
海关编码 | 2933990090 |
~% 尼芬那宗 2139-47-1 |
文献:Zorn; Schmidt Pharmazie, 1957 , vol. 12, p. 396,399 Full Text Show Details Heid Patent: DE897407 , 1951 ; Full Text Show Details Pongratz; Zirm Monatshefte fuer Chemie, 1957 , vol. 88, p. 330,332,333 |
~% 尼芬那宗 2139-47-1 |
文献:Zorn; Schmidt Pharmazie, 1957 , vol. 12, p. 396,399 |
~% 尼芬那宗 2139-47-1 |
文献:Pongratz; Zirm Monatshefte fuer Chemie, 1957 , vol. 88, p. 330,332,333 |
尼芬那宗上游产品 4 | |
---|---|
尼芬那宗下游产品 1 | |
海关编码 | 2933990090 |
---|---|
中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
Temporal endogenous gene expression profiles in response to lipid-mediated transfection.
J. Gene Med. 17(1-2) , 14-32, (2015) Design of efficient nonviral gene delivery systems is limited as a result of the rudimentary understanding of the specific molecules and processes that facilitate DNA transfer.Lipoplexes formed with L... |
|
[Nifenazone, biotransformation in humans].
Arch. Pharm. (Weinheim) 318(9) , 855-63, (1985)
|
Nicotazone |
nifenazone |
Nicoreumal |
Nicazane |
niphenazone |
1,5-Dimethyl-4-nicotinamido-2-phenyl-3-pyrazolone |
N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-nicotinamide |
Nicodone |
Nicophesone |
nicotinic acid-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-ylamide) |
Niapyrin |
Nicotinsaeure-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-ylamid) |
Nicofesone |
Nicophezon |
Phenicazone |